retatrutide gip glp-1 glucagon receptor agonist Explained: How the Triple Actually Works Retatrutide: The first-in-class investigational triple

GLP-1 use linked to fewer headaches in idiopathic intracranial hypertension Idiopathic intracranial hypertension is prevalent among young women with obesity

Endorphin Surge natural pain relief and brighter mood

Education on pen administration may help to reduce errors.

Roche presented early-stage data on its obesity injection and pill at EASD

A pivotal moment occurred in October 2022, just four months after Mounjaros launch, when Elon Musk admitted on Twitter (X) that taking Wegovy was his secret for looking fit and healthy. The post, and a subsequent tweet in 2024 that he was taking Mounjaro, went viral and sparked widespread curiosity around GLP-1s and their effectiveness on weight loss